9 May 2022: We’re looking for a Senior Manager, Regulatory Affairs, Cranford, NJ. See additional information here.

12 April 2022: Viona launches Levofloxacin Tablets, USP 

24 March 2022: Viona launches Doxycycline Hyclate Capsules, USP

7 January 2022: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg

11 June 2021: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg

We’re setting a new standard for high-quality, low-cost generics.


Viona Pharmaceuticals is an emerging generic pharmaceutical company established in May 2018 and located in Cranford, NJ. Viona is a wholly owned indirect subsidiary of Cadila Healthcare Limited, a fully integrated, global healthcare provider.

Learn More About Us

Levofloxacin Tablets, USP

COMPARED TO: Levaquin®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Synthetic Antibacterial Agent

Doxycycline Hyclate Capsules, USP

COMPARED TO: Vibramycin®
THERAPEUTIC RATING: AB
THERAPEUTIC CATEGORY: Antibacterial

PRODUCTS

Viona is currently marketing a range of Oral Solids and Topical products. We have a vast number of generic pharmaceutical products in the pipeline, which we are excited to introduce to the market soon.
Explore our Products

9 May 2022: We’re looking for a Senior Manager, Regulatory Affairs, Cranford, NJ. See additional information here.

12 April 2022: Viona launches Levofloxacin Tablets, USP 

24 March 2022: Viona launches Doxycycline Hyclate Capsules, USP

7 January 2022: Viona issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg